Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Tofacitinib effectively improved hair regrowth and skin condition in a woman with alopecia totalis and lichen planus hypertrophicus.

Immunotherapies for non-small cell lung cancer show promise in improving treatment and reducing side effects.

Topical tofacitinib may help regrow hair in children with alopecia totalis.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Amivantamab treatment often causes skin issues that can affect quality of life and treatment continuation.

Rhabdomyosarcoma is the most common head and neck cancer in children, requiring complex treatment.

Icariside II may help treat gastric cancer by stopping tumor growth.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Tofacitinib helps mice grow more hair by increasing noggin and BMP4 levels, possibly better than minoxidil.

Azathioprine can cause severe blood issues and hair loss, needing careful monitoring and possible discontinuation.

Intralesional pentoxifylline effectively and safely treats alopecia areata, improving hair regrowth.

IMSG nanoparticles improve vaccine delivery and immune response through hair follicles.

Compound 1 showed promising anticancer activity.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Silicate-based therapy may help treat inflammatory heart disease by reducing immune inflammation.

Zinc oxide nanoparticles made from Tridax procumbens leaves show strong antibacterial and anticancer effects.

Skin side effects from melanoma immunotherapy are common and may indicate better survival.

Iontophoresis improves minoxidil delivery for alopecia treatment.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Cetuximab can cause unusual hair growth and hair loss.

Oral tofacitinib effectively regrows hair in children with alopecia areata without major side effects.

Improving PROTAC delivery systems can enhance their effectiveness and speed up their use in medicine.

Rituximab may cause skin issues, but baricitinib can help improve them.

Isotretinoin shows promise as a treatment for Chagas disease by effectively inhibiting key transporters in the parasite.

Troglitazone increases subcutaneous fat in lipodystrophy patients.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

CVP therapy showed moderate success in treating advanced non-Hodgkin's lymphoma, but more intensive treatment is needed for better outcomes.

Cetuximab can cause excessive eyelash growth.